Dr. Perry is a Professor with the Department of Emergency Medicine, University of Ottawa, and a Senior Scientist with the Ottawa Hospital Research Institute. He completed the family medicine residency program at the Memorial University of Newfoundland and emergency medicine residency at the University of Manitoba and subsequently completed the Emergency Medicine Research Fellowship at the University of Ottawa, and obtained a Master of Science in Epidemiology in 2002. He holds a Research Chair in Emergency Neurological Research from the University of Ottawa. He previously held a Canadian Institutes for Health Research New Investigator Award and an Ontario Ministry of Health Career Scientist Award.
He is a peer reviewer for several granting agencies and journals. Dr. Perry supervises masters students in the Department of Epidemiology. Dr. Perry's research program is now very well-established and has published a large and growing number of peer-reviewed publications. His major research studies have been in the area of neurological emergencies. He has lead several large multicentre prospective clinical decision rule studies to improve care for patients with headache, subarachnoid hemorrhage (SAH), elderly patients with minor injuries at risk for subsequent functional decline and transient ischemic attack (TIA).
Hohl C, Hau J, Rosychuk R, Vaillancourt S, Grant J, Brooks S, Morrison L,
Perry JJ. Sensitivity and diagnostic yield of SARS-CoV-2 Nucleic Acid Amplification Testing in Patients presenting to hospital. JAMA Netw Open. 2022 Oct 3;5(10):e2236288. doi: 10.1001/jamanetworkopen.2022.36288.
Perry JJ, Sivilotti MLA, Emond M, Stiell IG, Stotts G, Lee J, Worster A, Morris J, Cheung KW, Jin AY, Oczkowski WJ, Sahlas DJ, Murray HE, Mackey A, Verreault S, Camden MC, Yip S, Teal P, Gladstone DJ, Boulos MI, Chagnon N, Shouldice E, Atzema C, Slaoui T, Teitlebaum J, Abdulaziz K, Nemnom MJ, Wells GA, Sharma M. A Prospective Cohort Study to Validate and Compare the Canadian TIA Score to the ABCD2 and ABCD2i for Subsequent Stroke Risk Following Transient Ischemic Attack. BMJ 2021;372:n49 (published online 4 Feb 2021).
Stiell IG, Sivilotti MLA, Taljaard M, Birnie D, Vadeboncoeur A, Hohl CM, McRae AD, Rowe BH, Brison RJ, Thiruganasambandamoorthy V, Macle L, Borgundvaag B, Morris J, Mercier E, Clement CM, Brinkhurst J, Sheehan C, Brown E, Nemnom MJ, Wells GA,
Perry JJ. Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial. Lancet. 2020 Feb 1;395(10221):339-349.
Perry JJ, Sivilotti MLA, Emond M, Hohl CM,
Khan M, Lesiuk H, Sutherland J, Abdulaziz K, Wells GA, Stiell IG.
Implementation of the Ottawa Subarachnoid Hemorrhage Rule and the 6-Hour CT
Rule in Patients with Acute Headache: A Prospective Implementation Study. Stroke. 2020 Feb;51(2):424-430.
